Cleared Special

K202169 - Quantum PureFlow Centrifugal Blood Pump CP37, Quantum PureFlow Centrifugal Blood Pump CP22 (FDA 510(k) Clearance)

Sep 2020
Decision
30d
Days
Class 2
Risk

K202169 is an FDA 510(k) clearance for the Quantum PureFlow Centrifugal Blood Pump CP37, Quantum PureFlow Centrifugal Blood Pump CP22. This device is classified as a Pump, Blood, Cardiopulmonary Bypass, Non-roller Type (Class II - Special Controls, product code KFM).

Submitted by Qura S.R.L (Mirandola, IT). The FDA issued a Cleared decision on September 2, 2020, 30 days after receiving the submission on August 3, 2020.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4360.

Submission Details

510(k) Number K202169 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 2020
Decision Date September 02, 2020
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code KFM - Pump, Blood, Cardiopulmonary Bypass, Non-roller Type
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4360